Michael Fehlings Selected Research

Michael Fehlings Research Topics

Disease

14	Neoplasms (Cancer) 01/2024 - 03/2017
6	COVID-19 01/2022 - 10/2020
5	Spinal Cord Injuries (Spinal Cord Injury) 01/2020 - 12/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 12/2016
3	Infections 01/2022 - 08/2012
3	Inflammation (Inflammations) 01/2021 - 08/2016
2	Spinal Cord Diseases 04/2024 - 12/2015
2	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2022
2	Wounds and Injuries (Trauma) 08/2016 - 10/2010
1	Paralysis (Palsy) 04/2024
1	Disease Progression 01/2024
1	Neoplasm Metastasis (Metastasis) 01/2024
1	Anaplastic Thyroid Carcinoma 01/2024
1	Stomach Neoplasms (Stomach Cancer) 01/2024
1	Human Influenza (Influenza) 10/2023
1	Virus Diseases (Viral Diseases) 10/2023
1	Chordoma 04/2023
1	Granuloma 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Yellow Fever 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Gliosis 07/2016
1	Hypothermia 07/2016
1	Cicatrix (Scar) 07/2016
1	Necrosis 07/2016
1	Radiculopathy (Radiculopathy, Cervical) 12/2015
1	Congenital Abnormalities (Deformity) 10/2015
1	Giardiasis 11/2013
1	Autonomic Dysreflexia 02/2012
1	Spinal Injuries (Spinal Injury) 12/2010
1	Coma (Comas) 12/2010
1	Central Cord Syndrome 10/2010
1	Neurologic Manifestations (Neurological Manifestations) 10/2010
1	Pathologic Constriction (Stenosis) 10/2010
1	Spondylosis 10/2010
1	Spinal Cord Compression 10/2010

Drug/Important Bio-Agent (IBA)

9	EpitopesIBA 01/2024 - 01/2018
6	AntigensIBA 01/2024 - 01/2018
5	Peptides (Polypeptides)IBA 01/2022 - 12/2019
4	Neutralizing AntibodiesIBA 01/2022 - 10/2020
3	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2020
3	RNA (Ribonucleic Acid)IBA 10/2023 - 11/2018
3	CytokinesIBA 01/2023 - 08/2016
3	AntibodiesIBA 01/2022 - 01/2020
3	N 30IBA 12/2021 - 02/2021
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2024 - 01/2022
2	atezolizumabIBA 01/2022 - 12/2019
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2022 - 12/2021
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2019
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2018
2	Methylprednisolone FDA LinkGeneric 01/2016 - 12/2010
1	pembrolizumabIBA 01/2024
1	Circulating Tumor DNAIBA 01/2024
1	NivolumabIBA 01/2024
1	B7-H1 AntigenIBA 01/2022
1	Surface Antigens (Surface Antigen)IBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	ProteomeIBA 10/2020
1	NectinsIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	ErbB Receptors (EGF Receptor)IBA 12/2016
1	Therapeutic UsesIBA 08/2016
1	DNA (Deoxyribonucleic Acid)IBA 07/2016
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 07/2016
1	Free RadicalsIBA 07/2016
1	MagnesiumIBA 07/2016
1	Minocycline (Cyclops)FDA LinkGeneric 07/2016
1	Chondroitin Sulfate ProteoglycansIBA 07/2016
1	Adenosine Triphosphate (ATP)IBA 07/2016
1	Glutamic Acid (Glutamate)FDA Link 07/2016
1	Riluzole FDA LinkGeneric 07/2016
1	LigandsIBA 11/2013
1	Interleukin-6 (Interleukin 6)IBA 08/2012
1	Interleukin-10 (Interleukin 10)IBA 08/2012
1	Macrophage Migration-Inhibitory FactorsIBA 08/2012
1	Interleukin-12 Subunit p40IBA 08/2012
1	Nerve Growth Factor (NGF)IBA 02/2012
1	Type A Botulinum Toxins (Botox)FDA Link 02/2012

Therapy/Procedure

8	Therapeutics 01/2024 - 07/2016
6	Immunotherapy 01/2024 - 03/2017
3	Decompression 04/2024 - 10/2010
3	Radiotherapy 01/2024 - 04/2023
2	Drug Therapy (Chemotherapy) 01/2024 - 03/2017
2	Surgical Decompression 01/2016 - 10/2010
1	Injections 01/2020
1	Intraperitoneal Injections 01/2020
1	Surgical Instruments (Clip) 08/2016
1	Cardiopulmonary Resuscitation (CPR) 12/2015
1	Spinal Fusion (Spondylosyndesis) 12/2015
1	Intravesical Administration 02/2012